| Authors: |
Solomon IH; Department of Pathology, Brigham and Women's Hospital, Boston, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, USA., De Girolami U; Department of Pathology, Brigham and Women's Hospital, Boston, USA., Chettimada S; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, USA., Misra V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, USA., Singer EJ; Department of Neurology and UCLA National Neurological AIDS Bank (NNAB), David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, USA., Gabuzda D; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, USA. dana_gabuzda@dfci.harvard.edu.; Department of Neurology, Harvard Medical School, Boston, USA. dana_gabuzda@dfci.harvard.edu.; CLS 1010, 450 Brookline Ave, Boston, MA, 02215, USA. dana_gabuzda@dfci.harvard.edu. |
